Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maha Ayyoub

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2010
Monitoring of NY-ESO-1 specific CD4+ T cells using molecularly defined MHC class II/His-tag-peptide tetramersMaha Ayyoub, Danijel Dojcinovic, Pascale Pignon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rateValérie Dutoit, Philippe Guillaume, Maha Ayyoub, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2009
Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma tMaha Ayyoub, Florence Deknuydt, Isabelle Raimbaud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2010
Assessment of vaccine-induced CD4 T cell responses to the 119-143 immunodominant region of the tumor-specific antigen NY-ESO-1 using DRB1*0101 tetramersMaha Ayyoub, Pascale Pignon, Danijel Dojcinovic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cellsDanila Valmori, Valeria Tosello, Naira E Souleimanian, et al.
Clinical Immunology (Orlando, Fla.)|July 5, 2005
Identification of B cell epitopes recognized by antibodies specific for the tumor antigen NY-ESO-1 in cancer patients with spontaneous immune responsesDanila Valmori, Naira E Souleimanian, Charles S Hesdorffer, et al.
Cancer Research|September 23, 2003
Tumor-reactive, SSX-2-specific CD8+ T cells are selectively expanded during immune responses to antigen-expressing tumors in melanoma patientsMaha Ayyoub, Donata Rimoldi, Philippe Guillaume, et al.
Cancer Research|July 17, 2012
CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunityNassima Redjimi, Caroline Raffin, Isabelle Raimbaud, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2009
Vaccination with a recombinant protein encoding the tumor-specific antigen NY-ESO-1 elicits an A2/157-165-specific CTL repertoire structurally distinct and of reduced tumor reactivity than that elicited by spontaneous immune responses to NY-ESO-1-expressing TumorsGilles Bioley, Philippe Guillaume, Immanuel Luescher, et al.
Cancer Immunology Research|May 29, 2014
Assessment of MAGE-A expression in resected non-small cell lung cancer in relation to clinicopathologic features and mutational status of EGFR and KRASMaha Ayyoub, Lorenzo Memeo, Emilio Alvarez-Fernández, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2010
Monitoring of NY-ESO-1 specific CD4+ T cells using molecularly defined MHC class II/His-tag-peptide tetramersMaha Ayyoub, Danijel Dojcinovic, Pascale Pignon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rateValérie Dutoit, Philippe Guillaume, Maha Ayyoub, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2009
Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma tMaha Ayyoub, Florence Deknuydt, Isabelle Raimbaud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2010
Assessment of vaccine-induced CD4 T cell responses to the 119-143 immunodominant region of the tumor-specific antigen NY-ESO-1 using DRB1*0101 tetramersMaha Ayyoub, Pascale Pignon, Danijel Dojcinovic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2006
Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cellsDanila Valmori, Valeria Tosello, Naira E Souleimanian, et al.
Clinical Immunology (Orlando, Fla.)|July 5, 2005
Identification of B cell epitopes recognized by antibodies specific for the tumor antigen NY-ESO-1 in cancer patients with spontaneous immune responsesDanila Valmori, Naira E Souleimanian, Charles S Hesdorffer, et al.
Cancer Research|September 23, 2003
Tumor-reactive, SSX-2-specific CD8+ T cells are selectively expanded during immune responses to antigen-expressing tumors in melanoma patientsMaha Ayyoub, Donata Rimoldi, Philippe Guillaume, et al.
Cancer Research|July 17, 2012
CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunityNassima Redjimi, Caroline Raffin, Isabelle Raimbaud, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2009
Vaccination with a recombinant protein encoding the tumor-specific antigen NY-ESO-1 elicits an A2/157-165-specific CTL repertoire structurally distinct and of reduced tumor reactivity than that elicited by spontaneous immune responses to NY-ESO-1-expressing TumorsGilles Bioley, Philippe Guillaume, Immanuel Luescher, et al.
Cancer Immunology Research|May 29, 2014
Assessment of MAGE-A expression in resected non-small cell lung cancer in relation to clinicopathologic features and mutational status of EGFR and KRASMaha Ayyoub, Lorenzo Memeo, Emilio Alvarez-Fernández, et al.
Pageof 9